Endpoint Health
Latest round
- Series A
Last raised
- Jun 2022
Total raised
- Undisclosed
Investors
- 10
About Endpoint Health
Founded in 2018 and based in California, US, Endpoint Health, Inc. operates as a biotechnology research company that develops therapies for patients affected by chronic diseases that are personalized for each patient's history. Jason Springs (CEO), Diego Rey (CSO), and Leonardo Maestri Teixeira (COO) are the co-founders of the company. In June 2022, Endpoint Health, Inc. The company's product pipeline includes EP004 anti-tissue factor mAb, EP006 antithrombin blood product, and EP005 anti-tissue factor mAb. The firm’s pipeline focuses on precision immunology, which leverages science and technology to deliver personalized treatment solutions that have immediate impacts on patient outcomes. The firm advances therapies to address unmet medical needs and improve patient outcomes by harnessing advanced technologies and strategic partnerships. Endpoint Health’s comprehensive clinical and data ecosystem supports the delivery of precision immunology to patients.
Who invested in Endpoint Health
10 investors across 1 round
See all investors in Endpoint Health
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jun 2, 2022
Amount
Undisclosed
Investors
Questions about Endpoint Health
Who invested in Endpoint Health?
Endpoint Health has 10 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Endpoint Health raised?
Endpoint Health has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Endpoint Health last raise money?
Endpoint Health's most recent round on record is a Series A, in Jun 2022.
What does Endpoint Health do?
Founded in 2018 and based in California, US, Endpoint Health, Inc.
Where is Endpoint Health headquartered?
Endpoint Health is headquartered in Palo Alto, US.
Which VCs invest in companies like Endpoint Health?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Endpoint Health's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Endpoint Health? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.